関連する実験動画
Updated: Feb 25, 2026

10:20
In vitro Measurements of Tracheal Constriction Using Mice
Published on: June 25, 2012
21.4K
アセプロマジンは,喘息のネズミモデルにおける呼吸道収縮を軽減する
Alembert Lino-Alvarado1, Maria Aparecida de Oliveira2, Carmen Silvia Moreno Serra2
1Biomedical Engineering Laboratory, Escola Politécnica, University of Sao Paulo, Sao Paulo, Brazil.
Clinical and experimental pharmacology & physiology
|February 23, 2026
まとめ
アセプロマジン (ACP) 鎮静剤は,喘息のモデルにおける呼吸器のメカニズムに影響を与える可能性があります. この鎮静剤は,呼吸道抵抗と滑らかな筋肉の反応性を低下させ,アレルギー性喘息の研究における研究結果を混乱させる可能性があります.
科学分野:
- 獣医薬理学 獣医薬理学について
- 呼吸器生理学 呼吸器生理学とは
- 免疫学 免疫学とは
背景:
- アセプロマジン (ACP) は,心血管効果が知られている一般的な獣医用鎮静剤です.
- 呼吸器の力学,特に喘息研究モデルにおけるその影響は,あまり理解されていない.
- 呼吸器機能の正確な評価は,臨床前の喘息研究において極めて重要です.
研究 の 目的:
- アセプロマジン (ACP) がアレルギー性喘息のマウリンモデルで呼吸器系メカニズムに及ぼす影響を調査する.
- 呼吸道滑らかな筋肉 (ASM) の反応に対するACPの影響を in vitroで評価する.
- 喘息研究におけるACPの潜在的混乱効果を決定する.
主な方法:
- BALB/cマウスは,アレルギー性喘息を誘発するために,オバルブミン (OVA) で感受性化されました.
- ネズミはケタミンとキシラジンと共にACP (2.5 mg/kg) を含む麻酔を受けた.
- 呼吸機構は,メタホリン (MCh) 挑戦後の強制振動技術 (FOT) を用いてin vivoで測定されました.
- 呼吸道滑らかな筋肉 (ASM) の反応性は,MCh.Ch.を使用してインビトロで評価されました.
主要な成果:
- ACPは,MChチャレンジ後のOVA感受性マウスのニュートン抵抗 (Rn) を著しく低下させた.
- ACPは,炎症性肺における組織ダッピング (G) とヒステリーシビリティ (η) の軽減された増加を伴いました.
- In vitroでは,ACPはASMのMCh濃度-応答曲線の右へのシフトを引き起こし,応答性の低下を示した.
結論:
- アセプロマジン (ACP) は,支氣管拡張効果を示し,呼吸道滑らかな筋肉の収縮性を低下させます.
- ACPの管理は,喘息のモデルにおける呼吸道過敏反応の評価を混乱させる可能性があります.
- 鎮静剤の選択を慎重に検討することは,喘息研究における呼吸器力学研究の科学的妥当性にとって不可欠です.
関連する概念動画
Antiasthma Drugs: Muscarinic Receptor Antagonists
1.9K
Muscarinic receptor antagonists, also known as antimuscarinic agents, are a class of bronchodilators used to treat asthma, although they are more commonly used to treat COPD. They work by inhibiting the action of acetylcholine (ACh), a neurotransmitter, on muscarinic receptors found in the airways.
Antimuscarinic agents compete with ACh for the same binding site on the muscarinic receptors. By binding to these receptors, they inhibit the downstream effects of ACh and block the parasympathetic...
Antimuscarinic agents compete with ACh for the same binding site on the muscarinic receptors. By binding to these receptors, they inhibit the downstream effects of ACh and block the parasympathetic...
1.9K
Asthma: Pathogenesis and Management
1.5K
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
1.5K
Adrenergic Agonists: Therapeutic Uses
2.0K
Adrenergic agonists have diverse therapeutic uses across various medical conditions and emergencies.
Emergency and Intensive Care Unit (ICU) applications: Pressor agents increase blood pressure, heart rate, and contractility in shock and organ failure situations. Dopamine can induce vasodilation and stimulate adrenoceptors. Endogenous catecholamines are effective in treating cardiogenic shock. α2-agonists like clonidine can reverse anesthesia-induced hypertension.
Allergies and...
Emergency and Intensive Care Unit (ICU) applications: Pressor agents increase blood pressure, heart rate, and contractility in shock and organ failure situations. Dopamine can induce vasodilation and stimulate adrenoceptors. Endogenous catecholamines are effective in treating cardiogenic shock. α2-agonists like clonidine can reverse anesthesia-induced hypertension.
Allergies and...
2.0K
Antiasthma Drugs: β2-Adrenoceptor Agonists
1.8K
Bronchodilators are critical in managing asthma, a chronic respiratory condition characterized by airway constriction due to inflammation and hyper-reactivity. Specifically, bronchodilators ease this constriction by relaxing the bronchial muscles, facilitating easier breathing.
One class of bronchodilators includes β2-adrenoceptor agonists. These agents target the β2-adrenoceptors located on bronchial smooth muscle cells. By stimulating these receptors, β2-agonists induce...
One class of bronchodilators includes β2-adrenoceptor agonists. These agents target the β2-adrenoceptors located on bronchial smooth muscle cells. By stimulating these receptors, β2-agonists induce...
1.8K
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
2.0K
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
2.0K
Antiasthma Drugs: Methylxanthines
1.8K
Theophylline, a member of the methylxanthine class of bronchodilators, has long been used in asthma management. While its exact mechanism of action is not fully understood, it is believed to have multiple effects on various cellular processes.
Theophylline is thought to inhibit phosphodiesterase enzymes, increasing intracellular levels of cyclic adenosine monophosphate (cAMP) and cyclic guanosine monophosphate (cGMP). This rise in cAMP and cGMP concentrations stimulates cardiac function,...
Theophylline is thought to inhibit phosphodiesterase enzymes, increasing intracellular levels of cyclic adenosine monophosphate (cAMP) and cyclic guanosine monophosphate (cGMP). This rise in cAMP and cGMP concentrations stimulates cardiac function,...
1.8K

